Composition for iontophoretic delivery of rotigotine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/381 (2006.01) A61K 9/00 (2006.01) A61K 47/00 (2006.01)

Patent

CA 2505040

By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corneum which was higher than the one previously obtained with conventional passive diffusion systems.

Le procédé décrit consiste à utiliser une composition contenant de la rotigotine et au moins un sel de chlorure à raison d'une concentration comprise entre 1 et 140 mmol/l, cette composition présentant un pH compris entre 4 et 6,5 dans un dispositif iontophorétique pour le traitement de la maladie de Parkinson. Ce procédé permet d'obtenir un flux de rotigotine à travers la couche cornée qui est plus important que celui obtenu précédemment avec les dispositifs conventionnels à diffusion passive.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for iontophoretic delivery of rotigotine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for iontophoretic delivery of rotigotine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for iontophoretic delivery of rotigotine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1879584

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.